Accelerate Diagnostics is an in vitro diagnostics company. The company's Accelerate Pheno? system utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial and fungal cells are resistant or susceptible to a particular antimicrobial. The Accelerate PhenoTest? BC Kit, which is the test kit for the system, provides ID and AST results for patients suspected of bacteremia or fungemia, both conditions with morbidity and mortality risk. The Accelerate Pheno? system comprises of a robotic pipettor for fluidic manipulation, an optical system, and an imaging system.

Amneal Pharmaceuticals is a holding companies. Through its subsidiaries, the company is a pharmaceutical company enganged in developing, manufacturing, marketing and distributing pharmaceutical products in a variety of dosage forms and therapeutic categories. The company's pharmaceutical research includes analytical and formulation development and stability. The company has two business segments: Generics, which products are sold either as branded or generic products; and Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including migraine and Parkinson's disease.

Axon Enterprise is provider of law enforcement technology solutions. The company's operations are comprised of two reportable segments: TASER, which is focused on development, manufacture and sale of conducted energy weapons, also known as conducted energy devices, which the company sells under its brand name, TASER; and software and sensors, which is focused on-officer body (Axon Body and Flex) and in-car (Axon Fleet) cameras as well as cloud-based digital evidence management software (Evidence.com), as well as develops, manufactures and sells hardware and cloud-based software solutions that enable law enforcement to capture, store, manage, share and analyze video and other digital evidence.

Blucora is a provider of technology-enabled financial solutions. The company has two reportable segments: Wealth Management and Tax Preparation. The Wealth Management business consists of the operations of Avantax Wealth Management, which provides tax-focused wealth management solutions for financial advisors, tax preparers, certified public accounting firms, and their clients and is a tax-focused independent broker-dealer. The Tax Preparation business consists of the operations of TaxAct, Inc., which provides digital do-it-yourself tax preparation solutions for consumers, small business owners and tax personnel through its website www.TaxAct.com.

Cadiz is a natural resources development company. The company's business is to acquire and develop land with water resources for various uses, including groundwater supply, groundwater storage and agriculture. The company's portfolio of land and water resource assets is located in proximity to the Colorado River and the Colorado River Aqueduct, the principal source of imported water for Southern California, and provides the company with the opportunity to participate in a variety of water supply, water storage, and conservation programs with public water agencies and other partners. The company's contiguous land in the Cadiz and Fenner valleys of eastern San Bernardino County, CA is zoned for agricultural development.

Capital Bancorp is a bank holding company. Through its subsidiary, Capital Bank, N.A. (the Bank), the company is principally engaged in the business of investing in commercial, real estate, and credit card loans and accepting deposits in Rockville, Columbia and North Bethesda, MD, Reston, VA, and the District of Columbia. The Bank operates three divisions: Commercial Banking, which provides commercial and industrial, commercial real estate and construction lending solutions; Church Street Mortgage, which originates conventional and government-guaranteed residential mortgage loans; and OpenSky?, which provides credit cards to under-banked populations and those looking to rebuild their credit scores.

Charles & Colvard manufactures, markets, and distributes Charles & Colvard Created Moissanite? (which the company refers to as moissanite or moissanite jewels) and finished jewelry featuring its proprietary moissanite gemstone for sale in the worldwide jewelry market. The company sells loose moissanite jewels and finished jewelry through various operating segments: its Online Channels segment, which comprises its charlesandcolvard.com website, e-commerce outlets, including marketplaces, drop-ship customers, and other e-commerce customers; and its Traditional segment, which consists of domestic and international distributors and retail customers.

Eyenovia is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing the company's patented piezo-print delivery technology, branded the Optejet?. The company's MicroStat is a fixed combination formulation of phenylephrine-tropicamide for mydriasis (pupil dilation). MicroPine is a topical therapy for the treatment of progressive myopia. MicroProst is a latanoprost formulation for lowering intraocular pressure in patients with ocular hypertension, primary open angle glaucoma, and chronic angle closure glaucoma. MicroTears is the company's over-the-counter product candidate for hyperemia (red eye), pruritis (itch) and dry eye.

Gaming & Leisure Properties is a self-administered and self-managed Pennsylvania real estate investment trust. The company's primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The company has two reportable segments: GLP Capital, L.P. (GLP Capital), which is a wholly-owned subsidiary of the company; and the TRS Properties. The GLP Capital reportable segment consists of the leased real property and represents the majority of the company's business. The TRS Properties reportable segment consists of Hollywood Casino Perryville and Hollywood Casino Baton Rouge.

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. JAKAFI (ruxolitinib) has been approved for the treatment of patients with intermediate or high-risk myelofibrosis, for the treatment of patients with polycythemia vera, and for the treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older. The company has also obtained a license to develop and commercialize ICLUSIG (ponatinib) in Europe and other select countries. In the European Union, ICLUSIG is approved for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia.

Insulet is engaged in the development, manufacturing and sale of its Omnipod? System, an insulin delivery system for people with insulin-dependent diabetes, which consists of two product lines: the Omnipod Insulin Management System and Omnipod DASH? Insulin Management System. The Omnipod System features a self-adhesive disposable tubeless Pod, which is worn on the body and provides up to three days of non-stop insulin delivery without the need to see or handle a needle, and a handheld Personal Diabetes Manager. The Omnipod System communicates wirelessly, provides for automated cannula insertion and eliminates the need for multiple daily injection therapy or the use of pump and tubing.

Net 1 UEPS Technologies provides financial technology, products and services. The company has developed and owns most of its payment technologies, and where possible, utilizes this technology to provide financial and services to its customers by including them into the formal financial system. The company's primary payment technology is called the Universal Electronic Payment System (UEPS), and its EMV interoperable derivative, UEPS/EMV, utilizes a form of distributed ledger technology, providing decentralized and biometrically secure smart cards that operate in real-time but both off-line and on-line. The company's financial inclusion products and services are delivered through its UEPS-based core banking system.

Parsons is a provider of technology-driven solutions in the defense, intelligence and critical infrastructure markets. The company provides technical design and engineering services and software to address the company's customers' challenges. The company has developed significant expertise and differentiated capabilities in key areas of cybersecurity, intelligence, defense, military training, connected communities, physical infrastructure and mobility solutions. The company performs work in various foreign countries through local subsidiaries, joint ventures and foreign offices maintained to carry out specific projects.

PetIQ is a holding company. Through its subsidiaries, the company is a pet medication and wellness company providing veterinary products and services. The company's Rx pet medications include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications, all of which require a prescription from a veterinarian. The OTC medications the company sells are primarily comprised of flea and tick control products, which are available in multiple forms that consumers choose between, such as spot on (topical) treatments, chewables, and collars. The company's health and wellness products include treats and other pet products such as dental treats and nutritional supplements.

Tela Bio is a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's products are an innovative solution that integrate multiple layers of minimally-processed biologic material with interwoven polymers in a unique embroidered pattern, which the company refers to as a reinforced tissue matrix. The company serves customers in the United States.

Venus Concept is a medical technology company developing and commercializing a robotic device, the ARTAS? System, that assists physicians in performing tasks that are a part of a follicular unit extraction surgery. The ARTAS? System includes the ARTAS Hair Studio application, a three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. The ARTAS? System is comprised of the patient chair, the cart, which includes the robotic arm, vision system, artificial intelligence algorithms and a series of proprietary end effectors, which are the various devices at the end of the robotic arm.